RC
TECH icon

RegentAtlantic Capital’s Bio-Techne TECH Stock Holding History

RegentAtlantic Capital’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$320K Sell
4,512
-36
-0.8% -$3.11K 0.01% 550
2022
Q2 		$394K Sell
4,548
-2,084
-31% -$195K 0.01% 486
2022
Q1 		$718K Buy
+6,632
New +$684K 0.02% 379

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

RegentAtlantic Capital's TECH Position: Q3 2022 in Review

RegentAtlantic Capital reduced its Bio-Techne (TECH) stake by 0.79% in Q3 2022, selling an estimated $3.11K and leaving 4,512 shares worth $320K. The position accounts for 0.01% of the portfolio, ranked #550.

RegentAtlantic Capital first reported a position in TECH in Q1 2022 and has held it in 3 quarters since. The position peaked at $718K in Q1 2022. 535 funds tracked by Wall St. Rank hold TECH as of Q3 2022.

  • RegentAtlantic Capital held 4,512 shares of Bio-Techne worth $320K as of Q3 2022.
  • RegentAtlantic Capital sold 36 Bio-Techne shares in Q3 2022, an estimated $3.11K.
  • Bio-Techne made up 0.01% of RegentAtlantic Capital's portfolio in Q3 2022, its #550 holding.
  • RegentAtlantic Capital first reported a position in Bio-Techne in Q1 2022 and has held it in 3 quarters since.
  • RegentAtlantic Capital's Bio-Techne position peaked at $718K in Q1 2022.
  • 535 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2022.

Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.